Title : Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease.

Pub. Date : 2010 Mar 8

PMID : 20211007






4 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 We therefore explored whether the known NFkappaB inhibitor celastrol could represent a suitable compound for decreasing Abeta production and accumulation in vivo. celastrol amyloid beta (A4) precursor protein Mus musculus
2 METHODS: The effect of celastrol on amyloid precursor protein (APP) processing, Abeta production and NFkappaB activation was investigated by western blotting and ELISAs using a cell line overexpressing APP. celastrol amyloid beta (A4) precursor protein Mus musculus
3 In addition, a reduction in Abeta plaque burden and microglial activation was observed in the brains of Tg PS1/APPsw following a chronic administration of celastrol. celastrol amyloid beta (A4) precursor protein Mus musculus
4 CONCLUSIONS: Overall our data suggest that celastrol is a potent Abeta lowering compound that acts as an indirect BACE-1 inhibitor possibly by regulating BACE-1 expression level via an NFkappaB dependent mechanism. celastrol amyloid beta (A4) precursor protein Mus musculus